These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35122056)

  • 1. LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2-cFLIP-NF-κB signaling axis.
    Wu G; Xu Y; Schultz RD; Chen H; Xie J; Deng M; Liu X; Gui X; John S; Lu Z; Arase H; Zhang N; An Z; Zhang CC
    Nat Cancer; 2021 Nov; 2(11):1170-1184. PubMed ID: 35122056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.
    Mai S; Hodges A; Chen HM; Zhang J; Wang YL; Liu Y; Nakatsu F; Wang X; Fang J; Xu Y; Davidov V; Kang K; Pingali SR; Ganguly S; Suzuki M; Konopleva M; Prinzing B; Zu Y; Gottschalk S; Lu Y; Chen SH; Pan PY
    Cancer Res; 2023 Dec; 83(24):4047-4062. PubMed ID: 38098451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development.
    Huang R; Liu X; Kim J; Deng H; Deng M; Gui X; Chen H; Wu G; Xiong W; Xie J; Lewis C; Homsi J; Yang X; Zhang C; He Y; Lou Q; Smith C; John S; Zhang N; An Z; Zhang CC
    Cancer Immunol Res; 2024 Mar; 12(3):350-362. PubMed ID: 38113030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma.
    Fan J; Li J; Han J; Zhang Y; Gu A; Song F; Duan J; Yin D; Wang L; Yi Y
    Mol Immunol; 2021 Aug; 136():82-97. PubMed ID: 34098344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
    Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H
    Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation.
    Yeboah M; Papagregoriou C; Jones DC; Chan HTC; Hu G; McPartlan JS; Schiött T; Mattson U; Mockridge CI; Tornberg UC; Hambe B; Ljungars A; Mattsson M; Tews I; Glennie MJ; Thirdborough SM; Trowsdale J; Frendeus B; Chen J; Cragg MS; Roghanian A
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32870822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.
    Alvarez SE; Harikumar KB; Hait NC; Allegood J; Strub GM; Kim EY; Maceyka M; Jiang H; Luo C; Kordula T; Milstien S; Spiegel S
    Nature; 2010 Jun; 465(7301):1084-8. PubMed ID: 20577214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PP4R1 subunit of protein phosphatase PP4 targets TRAF2 and TRAF6 to mediate inhibition of NF-κB activation.
    Hadweh P; Habelhah H; Kieff E; Mosialos G; Hatzivassiliou E
    Cell Signal; 2014 Dec; 26(12):2730-7. PubMed ID: 25134449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
    Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
    J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.
    Varfolomeev E; Goncharov T; Maecker H; Zobel K; Kömüves LG; Deshayes K; Vucic D
    Sci Signal; 2012 Mar; 5(216):ra22. PubMed ID: 22434933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-κB inactivation to regulate breast cancer cell invasion.
    Jang KW; Lee KH; Kim SH; Jin T; Choi EY; Jeon HJ; Kim E; Han YS; Chung JH
    J Cell Biochem; 2011 Dec; 112(12):3612-20. PubMed ID: 21793045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Orphan Immune Receptor LILRB3 Modulates Fc Receptor-Mediated Functions of Neutrophils.
    Zhao Y; van Woudenbergh E; Zhu J; Heck AJR; van Kessel KPM; de Haas CJC; Aerts PC; van Strijp JAG; McCarthy AJ
    J Immunol; 2020 Feb; 204(4):954-966. PubMed ID: 31915259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
    Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T
    J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
    Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
    J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E3 ubiquitin ligase TRAF2 can contribute to TNF-α resistance in FLT3-ITD-positive AML cells.
    Schnetzke U; Fischer M; Spies-Weisshart B; Zirm E; Hochhaus A; Müller JP; Scholl S
    Leuk Res; 2013 Nov; 37(11):1557-64. PubMed ID: 23998902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.
    Borghi A; Verstrepen L; Beyaert R
    Biochem Pharmacol; 2016 Sep; 116():1-10. PubMed ID: 26993379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siva-1 promotes K-48 polyubiquitination of TRAF2 and inhibits TCR-mediated activation of NF-kappaB.
    Gudi R; Barkinge J; Hawkins S; Prabhakar B; Kanteti P
    J Environ Pathol Toxicol Oncol; 2009; 28(1):25-38. PubMed ID: 19392652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
    Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
    Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells.
    So T; Soroosh P; Eun SY; Altman A; Croft M
    Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2903-8. PubMed ID: 21282629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.